1302 — LifeTech Scientific Share Price
Last trade - 00:00- HK$6.67bn
- HK$5.99bn
- CNY1.30bn
- 72
- 27
- 52
- 51
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 17.44 | ||
| PEG Ratio (f) | 1.12 | ||
| EPS Growth (f) | 18.38% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.82 | ||
| Price to Tang. Book | 2.3 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.87 | ||
| EV to EBITDA | 26.23 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.56% | ||
| Return on Equity | 6.48% | ||
| Operating Margin | 14.29% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 642.3 | 925.33 | 1,097.31 | 1,267.17 | 1,303.7 | 1,686.75 | 2,075.69 | 14.28% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +54.37 | +30.76 | +19.9 | -22.44 | +8.24 | +15.09 | +24.66 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
LifeTech Scientific Corp is a company principally engaged in the development, manufacturing and marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company operates through three segments. The Structural Heart Diseases Business segment is engaged in the trading and manufacturing of congenital heart diseases occluders and left atrial appendage (LAA) occluders. The Peripheral Vascular Diseases Business segment is engaged in the trading and manufacturing of vena cava filters and stent grafts. The Cardiac Pacing and Electrophysiology Business segment is engaged in the trading and manufacturing of pacemakers. The Company mainly conducts its businesses in the domestic and foreign markets.
Directors
- Yuehui Xie CHM (45)
- Jianxiong Liu CFO (46)
- Jiangbo Han COO (54)
- Deyuan Zhang CSO (54)
- Mark Cibuzar DSL (57)
- Sajeevan Manikkoth DSL (43)
- Guowei Zhan DSL (45)
- Feng Jiang NED (55)
- Hsien-Tse Liang NID (60)
- Wansong Wang NID (48)
- Luming Zhou NID (56)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 17th, 2006
- Public Since
- November 10th, 2011
- No. of Employees
- 1,392
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 4,630,612,400
- Address
- LifeTech Scientific Building, No.22, Kej, SHENZHEN, 518063
- Web
- https://www.lifetechmed.com/
- Phone
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for 1302
Similar to 1302
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 21:45 UTC, shares in LifeTech Scientific are trading at HK$1.46. This share price information is delayed by 15 minutes.
Shares in LifeTech Scientific last closed at HK$1.46 and the price had moved by -10.98% over the past 365 days. In terms of relative price strength the LifeTech Scientific share price has underperformed the FTSE Developed Asia Pacific Index by -9.96% over the past year.
The overall consensus recommendation for LifeTech Scientific is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreLifeTech Scientific does not currently pay a dividend.
LifeTech Scientific does not currently pay a dividend.
LifeTech Scientific does not currently pay a dividend.
To buy shares in LifeTech Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$1.46, shares in LifeTech Scientific had a market capitalisation of HK$6.67bn.
Here are the trading details for LifeTech Scientific:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1302
Based on an overall assessment of its quality, value and momentum LifeTech Scientific is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in LifeTech Scientific is HK$1.82. That is 24.92% above the last closing price of HK$1.46.
Analysts covering LifeTech Scientific currently have a consensus Earnings Per Share (EPS) forecast of CNY0.07 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LifeTech Scientific. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +1.78%.
As of the last closing price of HK$1.46, shares in LifeTech Scientific were trading -2.08% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The LifeTech Scientific PE ratio based on its reported earnings over the past 12 months is 17.44. The shares last closed at HK$1.46.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
LifeTech Scientific's management team is headed by:
- Yuehui Xie - CHM
- Jianxiong Liu - CFO
- Jiangbo Han - COO
- Deyuan Zhang - CSO
- Mark Cibuzar - DSL
- Sajeevan Manikkoth - DSL
- Guowei Zhan - DSL
- Feng Jiang - NED
- Hsien-Tse Liang - NID
- Wansong Wang - NID
- Luming Zhou - NID